In a randomized, double-blind, placebocontrolled study to evaluate the efficacy of trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia, we studied 160 patients with cancer who were at high risk for this pneumonia over a two-year period. Seventeen of the 80 patients receiving a placebo acquired P. carinii pneumonitis, whereas none of the 80 given 150 mg of trimethoprim and 750 mg of sulfamethoxazole per square meter per day had the infection P less than 0.01). Bacterial sepsis, pneumonia other than that caused by P. carinii, acute otitis media, upper-respiratory-tract infections, sinusitis and cellulitis occurred less frequently in recipients of the drug than in the placebo group (P less than 0.01 in each case). Oral candidiasis was the only adverse effect ecountered from trimethoprim-sulfamethoxazole administration. The study shows the combination to be highly effective in the prevention of P. carinii pneumonitis.
This article has been cited by other articles:
Davis, J L, Welsh, D A, Beard, C B, Jones, J L, Lawrence, G G, Fox, M R, Crothers, K, Morris, A, Charbonnet, D, Swartzman, A, Huang, L
(2008). Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia. Thorax
63: 329-334
[Abstract][Full Text]
Lindemulder, S., Albano, E.
(2007). Successful Intermittent Prophylaxis With Trimethoprim/Sulfamethoxazole 2 Days per Week for Pneumocystis carinii (jiroveci) Pneumonia in Pediatric Oncology Patients. Pediatrics
120: e47-e51
[Abstract][Full Text]
Rodriguez, M., Fishman, J. A.
(2004). Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients. Clin. Microbiol. Rev.
17: 770-782
[Abstract][Full Text]
Gilmartin, G. S., Koziel, H.
(2002). Pneumocystis Carinii Pneumonia in Adult Non-HIV Disorders. J Intensive Care Med
17: 283-301
[Abstract]
Wininger, D. A., Fass, R. J.
(2002). Impact of Trimethoprim-Sulfamethoxazole Prophylaxis on Etiology and Susceptibilities of Pathogens Causing Human Immunodeficiency Virus-Associated Bacteremia. Antimicrob. Agents Chemother.
46: 594-597
[Abstract][Full Text]
Kovacs, J. A., Gill, V. J., Meshnick, S., Masur, H.
(2001). New Insights Into Transmission, Diagnosis, and Drug Treatment of Pneumocystis carinii Pneumonia. JAMA
286: 2450-2460
[Abstract][Full Text]
Kerr, K. G.
(1999). The prophylaxis of bacterial infections in neutropenic patients. J Antimicrob Chemother
44: 587-591
[Full Text]
Pui, C.-H., Boyett, J. M., Hughes, W. T., Rivera, G. K., Hancock, M. L., Sandlund, J. T., Synold, T., Relling, M. V., Ribeiro, R. C., Crist, W. M., Evans, W. E.
(1997). Human Granulocyte Colony-Stimulating Factor after Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia. NEJM
336: 1781-1787
[Abstract][Full Text]
Hughes, W. T., Mortier, E., Pouchot, J., Molinie, V., Simonds, R.J., Lindegren, M. L., Thomas, P.
(1995). Pneumocystis in Infants and Children. NEJM
333: 320-321
[Full Text]
Simonds, R.J., Lindegren, M. L., Thomas, P., Hanson, D., Caldwell, B., Scott, G., Rogers, M., The Pneumocystis carinii Pneumonia Prophylaxis Eva,
(1995). Prophylaxis against Pneumocystis carinii Pneumonia among Children with Perinatally Acquired Human Immunodeficiency Virus Infection in the United States. NEJM
332: 786-790
[Abstract][Full Text]
Mofenson, L. M., Nugent, R., Spector, S. A., Gelber, R. D., Wara, D. W.
(1995). Prophylactic Immune Globulin in Children with HIV Disease. NEJM
332: 750-752
[Full Text]
Rivera, G. K., Pinkel, D., Simone, J. V., Hancock, M. L., Crist, W. M.
(1993). Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital. NEJM
329: 1289-1295
[Abstract][Full Text]
Girard, P.-M., Landman, R., Gaudebout, C., Olivares, R., Saimot, A. G., Jelazko, P., Gaudebout, C., Certain, A., Boue, F., Bouvet, E., Lecompte, T., Jean-Coulaud, P., The PRIO Study Group,
(1993). Dapsone-Pyrimethamine Compared with Aerosolized Pentamidine as Primary Prophylaxis against Pneumocystis carinii Pneumonia and Toxoplasmosis in HIV Infection. NEJM
328: 1514-1520
[Abstract][Full Text]
Paar, D., Masur, H.
(1992). Advances in the Management of Major Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection. Journal of Pharmacy Practice
5: 131-142
Lampe, R. M., Weir, M. R.
(1986). Erythromycin Prophylaxis for Recurrent Otitis Media. CLIN PEDIATR
25: 510-515
[Abstract]
Zarin, D. A., Pauker, S. G.
(1983). Bilateral Pulmonary Infiltrates in an 11-Year-Old with Acute Lymphocytic Leukemia: Is a Chance to Cut Really a Chance to Cure?. Med Decis Making
3: 247-269
Previous
